Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Granulocytes
  • Immunoglobulin G
  • Neuroblastoma

abstract

  • GM-CSF-induced granulocyte activation in vivo is associated with improved patient outcome. This activation was more apparent when GM-CSF was given by the SC route instead of IV route.

publication date

  • February 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3269968

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.37.6236

PubMed ID

  • 22203761

Additional Document Info

start page

  • 426

end page

  • 32

volume

  • 30

number

  • 4